Nucleus Software Exports (531209) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
9 Jul, 2026Executive summary
Revenue and profit declined both sequentially and year-over-year, attributed to a focus on long-term talent retention and strategic investments rather than short-term financials.
Management remains confident in a financial rebound in upcoming quarters and is prioritizing long-term enterprise value.
A major strategic initiative, Hoshin Kanri, is underway to drive continuous improvement and enhance customer experience.
Audited standalone and unaudited consolidated financial results for the quarter ended June 30, 2024, were reviewed and approved by the Board and Audit Committee on August 3, 2024.
Statutory auditors expressed an unmodified opinion on standalone results and a clean review conclusion on consolidated results.
Financial highlights
Consolidated revenue for the quarter was INR 195.4 crore, down from INR 210.3 crore quarter-over-quarter and INR 206.81 crore year-over-year.
Product revenue was INR 168 crore, and services revenue was INR 27.4 crore.
Total comprehensive income was INR 31.2 crore, compared to INR 46.1 crore in the previous quarter and INR 56.6 crore year-over-year.
EPS for the quarter was INR 11.28, down from INR 19.48 quarter-over-quarter and INR 20.00 year-over-year.
Cash and cash equivalents stood at INR 920.8 crore as of June 30, 2024.
Outlook and guidance
Management expects improvement from the current quarter's bottom-line performance but did not provide specific revenue or margin guidance.
Growth is anticipated in international markets, with ongoing customer conversations in multiple geographies.
Latest events from Nucleus Software Exports
- Order book doubled with strong new wins, but profit and margins declined sharply.531209
Q1 26/2731 Jul 2026 - Quarterly revenue reached INR 200.03 crore; profit dipped due to labor code impact and AI progress continued.531209
Q3 25/269 Jul 2026 - Revenue and profit declined sequentially, but capital returns and auditor approval marked the period.531209
Q2 25/268 Jul 2026 - Revenue rose but net profit and EBITDA fell due to Labour Codes impact; dividend proposed.531209
Q4 25/2622 May 2026 - Revenue and profit rose year-over-year, with robust order book, dividend, buyback, and product go-lives.531209
Q1 25/263 Feb 2026 - Sequential profit and revenue growth, strong cash, but longer sales cycles slow order conversion.531209
Q2 24/2514 Jan 2026 - Quarterly revenue and profit rose, with strong order book and shareholder returns.531209
Q3 24/259 Jan 2026 - Revenue up, profit down year-over-year, dividend and buyback mark capital return.531209
Q4 24/2526 Nov 2025